相似文献
1
Lessons from international experience in controlling pharmaceutical expenditure. II: Influencing doctors.
BMJ. 1996 Jun 15;312(7045):1525-7. doi: 10.1136/bmj.312.7045.1525.
2
Lessons from international experience in controlling pharmaceutical expenditure. I: Influencing patients.
BMJ. 1996 Jun 8;312(7044):1469-71. doi: 10.1136/bmj.312.7044.1469.
3
French regulatory medical references are criteria, not clinical guidelines.
BMJ. 1996 Sep 28;313(7060):818. doi: 10.1136/bmj.313.7060.818a.
4
Evaluating prescribing interventions.
Br J Gen Pract. 2002 May;52(478):412-3.
5
Allocating prescribing budgets. Limitations of formula should have been stated more clearly.
BMJ. 2000 Jul 8;321(7253):113.
6
Prescribing behaviour after the introduction of decentralized drug budgets: is there an association with employer and type of care facility?
Scand J Prim Health Care. 2009;27(2):117-22. doi: 10.1080/02813430902793225.
7
New formula for GP prescribing budgets. General practitioners in England need to understand its implications.
BMJ. 2000 Jan 29;320(7230):266. doi: 10.1136/bmj.320.7230.266.
8
Prescribing costs and patterns: authors' response.
Br J Gen Pract. 2002 Jul;52(480):587.
9
Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.
PLoS Med. 2010 Oct 19;7(10):e1000352. doi: 10.1371/journal.pmed.1000352.
10
Twenty-Year Nationwide Trends in Statin Utilization and Expenditure in Denmark.
Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7). doi: 10.1161/CIRCOUTCOMES.117.003811.
引用本文的文献
1
Managing Pharmaceutical Costs in Health Systems: A Review of Affordability, Accessibility and Sustainability Strategies.
J Mark Access Health Policy. 2024 Dec 10;12(4):403-414. doi: 10.3390/jmahp12040031. eCollection 2024 Dec.
2
Relationship between the number of hospital pharmacists and hospital pharmaceutical expenditure: a macro-level panel data model of fixed effects with individual and time.
BMC Health Serv Res. 2020 Feb 5;20(1):91. doi: 10.1186/s12913-020-4907-2.
3
Effectiveness of audit and feedback in addressing over prescribing of antibiotics and injectable medicines in a middle-income country: an RCT.
Daru. 2019 Jun;27(1):101-109. doi: 10.1007/s40199-019-00248-5. Epub 2019 Feb 21.
4
Relationship Between the Provision of Injection Services in Ambulatory Physician Offices and Prescribing Injectable Medicines.
Iran J Pharm Res. 2017 Winter;16(1):399-403.
5
Pharmaceutical policies: effects of financial incentives for prescribers.
Cochrane Database Syst Rev. 2015 Aug 4;2015(8):CD006731. doi: 10.1002/14651858.CD006731.pub2.
6
International experience in controlling pharmaceutical expenditure: influencing patients and providers and regulating industry - a systematic review.
J Health Serv Res Policy. 2015 Jan;20(1):52-9. doi: 10.1177/1355819614545675. Epub 2014 Aug 4.
7
Evaluating patients' perceptions regarding generic medicines in Jordan.
J Pharm Policy Pract. 2013 Jun 13;6:3. doi: 10.1186/2052-3211-6-3. eCollection 2013.
8
Assessing the effectiveness and cost-effectiveness of audit and feedback on physician's prescribing indicators: study protocol of a randomized controlled trial with economic evaluation.
Daru. 2012 Dec 6;20(1):88. doi: 10.1186/2008-2231-20-88.
9
It is a good time to expand your circle!
Anesth Analg. 2011 Nov;113(5):1279-81. doi: 10.1213/ANE.0b013e31822d39e6.
10
Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey.
BMC Public Health. 2007 Jun 25;7:122. doi: 10.1186/1471-2458-7-122.
本文引用的文献
1
New developments in pricing and drug reimbursement in France.
Pharmacoeconomics. 1994;6 Suppl 1:28-35. doi: 10.2165/00019053-199400061-00009.
2
The New Zealand preferred medicines concept: a national scheme for audit and quality assurance of prescribing.
Pharmacoeconomics. 1994 Jul;6(1):5-14. doi: 10.2165/00019053-199406010-00002.
3
Introducing a market to the United Kingdom's National Health Service.
N Engl J Med. 1996 Feb 29;334(9):604-8. doi: 10.1056/NEJM199602293340918.
4
The effects of fundholding in general practice on prescribing habits three years after introduction of the scheme.
BMJ. 1995 Dec 9;311(7019):1543-7. doi: 10.1136/bmj.311.7019.1543.
5
Subcortical dementia.
BMJ. 1993 Jul 3;307(6895):1-2. doi: 10.1136/bmj.307.6895.1.
6
Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs.
BMJ. 1993 Nov 6;307(6913):1186-9. doi: 10.1136/bmj.307.6913.1186.
7
The German health care system at the crossroads.
Health Econ. 1994 Sep-Oct;3(5):301-3. doi: 10.1002/hec.4730030503.
8
Motivation for hepatitis B vaccine acceptance among medical and physician assistant students.
J Gen Intern Med. 1995 Jan;10(1):1-6. doi: 10.1007/BF02599567.
9
Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene.
Am J Public Health. 1987 Dec;77(12):1518-23. doi: 10.2105/ajph.77.12.1518.
10
Principles of educational outreach ('academic detailing') to improve clinical decision making.
JAMA. 1990 Jan 26;263(4):549-56.
Zotero 插件